Related by context. All words. (Click for frequent words.) 77 Prolongs Survival 76 Fungal Infections 76 Invasive Fungal Infections 75 Pulmonary Arterial Hypertension 75 Chemotherapy Induced 75 Meets Primary Endpoint 75 Clinical Outcome 74 Immunotherapeutic 74 Regenerative Cells 74 FDA Approvals 74 Receives Orphan Drug Designation 74 Minimally Invasive Treatment 74 Advanced Melanoma 74 Antitumor Activity 74 Initiate Clinical Trial 74 Phase 2b Clinical Trial 74 Diabetic Neuropathy 74 Severe Sepsis 73 Complicated Skin 73 Atopic Dermatitis 73 Drug Candidate 73 Advanced Renal Cell 73 Adjuvant Treatment 73 Tyrosine Kinase Inhibitor 73 Aliskiren 73 Initiates Clinical Trial 73 Improves Survival 73 Oral Fingolimod 73 Novel Oral 73 Combination Therapy 72 Renal Cancer 72 Allogeneic 72 Single Dose 72 Chronic Sinusitis 72 Renal Cell Carcinoma 72 Investigational Treatment 72 Demonstrates Significant 72 Overactive Bladder 72 Myelodysplastic Syndromes 72 Diabetic Foot Ulcer 72 Brain Metastases 72 Study Evaluating 72 Metastatic Melanoma 72 Anti Tumor 72 Demonstrates Positive 72 Neoadjuvant Chemotherapy 72 RNAi Therapeutic 72 Patient Enrollment 72 Adjuvant Chemotherapy 72 Hepatocellular Carcinoma 72 Acute Heart Failure 72 Gastric Cancer 72 Immune Responses 72 Clinical Trial Results 72 Hsp# Inhibitor 72 Initiates Clinical 71 Phase 2b Trial 71 Receives Orphan Drug 71 Preclinical Data 71 Improves Outcomes 71 Metastatic Colorectal Cancer 71 Topical Treatment 71 Phase 2b Study 71 Mouse Model 71 Gets FDA Clearance 71 Initiates Enrollment 71 Antiplatelet 71 Milestone Payment 71 Files IND 71 Antifungal 71 Embolization 71 Acute Ischemic Stroke 71 Phase IIb Trial 71 Transdermal Patch 71 Fondaparinux 71 Contrast Agents 71 Present Preclinical Data 71 Inhaled Corticosteroids 71 Anticancer Agent 71 Patients Receiving 71 Anti Inflammatory Drug 71 Proven Effective 71 Disease Progression 71 Hormone Refractory Prostate Cancer 71 Preclinical Study 71 Intravascular 71 Achieves Primary Endpoint 71 Chronic Hepatitis C 70 Liver Injury 70 Phase III Clinical Trial 70 Catheter Associated 70 Adjuvant Therapy 70 Progenitor Cells 70 Metastatic Prostate Cancer 70 Phase IIb Clinical Trial 70 First Patient Treated 70 Osteoporosis Treatment 70 Endovascular Treatment 70 Survival Benefit 70 Inhalation Solution 70 Novel Mechanism 70 Phase IIa Clinical Trial 70 JAK Inhibitor 70 Clinical Trial Data 70 Epidermal Growth Factor Receptor 70 Schizophrenia Treatment 70 Invasive Breast Cancer 70 Treating Chronic 70 Hypercholesterolemia 70 Autoimmune Diseases 70 HER2 Positive Breast Cancer 70 Allergic Rhinitis 70 Orally Active 70 Breast Cancer Recurrence 70 Shows Promise Against 70 Low Dose 70 Patients Suffering 70 Monoclonal Antibody 70 Phase 2a Clinical Trial 70 Improved Survival 70 Prophylactic Treatment 70 Combo Therapy 70 Ischemic 70 Prospective Randomized 70 Serious Infections 70 Is Well Tolerated 70 Presents Preclinical Data 70 Expanded Indication 70 Interferon Alfa 70 Tumor Response 70 Randomized Clinical Trial 70 NDA Submission 70 Demonstrates Potential 70 Immunomodulatory 70 Kinase Inhibitor 70 Completes Patient Enrollment 70 FDA APPROVES 70 Protease Inhibitor 70 First Patient Dosed 70 Oral Insulin 70 Drug Shows Promise 70 Skin Lesions 70 samarium Sm 70 Patients Treated With 70 lexidronam injection 70 Analytical Tool 70 Successfully Completes Phase 70 Minimally Invasive Procedure 70 Myelofibrosis 70 Demonstrates Efficacy 70 JAK2 Inhibitor 70 Drug Prevents 70 Previously Treated 70 Transdermal Delivery 70 Kidney Transplant Patients 70 Investigational Compound 70 Demonstrates Ability 70 Immunosuppressant 70 Tumor Targeting 70 Interferon Beta 69 Lymphoid 69 Replacement Therapy 69 Granted Orphan Drug 69 See CLINICAL PHARMACOLOGY 69 Elderly Patients 69 Treatment Reduces 69 Anthracycline 69 Novel Inhibitor 69 Proves Effective 69 Solid Tumors 69 Thrombotic 69 IND Application 69 Node Positive 69 Aurora Kinase 69 Virus Infection 69 Diabetic Foot Ulcers 69 Secondary Hyperparathyroidism 69 Soft Tissue Sarcoma 69 Breast Tumors 69 Hormone Receptor Positive 69 Combination Treatment 69 Shows Promising 69 Coronary Arteries 69 Demonstrates Potent 69 Interferon Gamma 69 Benign Prostatic Hyperplasia 69 Fast Track Status 69 FDA Okays 69 Pharmacokinetic Study 69 Percutaneous Tibial Nerve Stimulation 69 Rheumatoid Arthritis Drug 69 Rheumatoid Arthritis Patients 69 Vaccine Candidate 69 HER2 Positive 69 Bazedoxifene 69 Vascular Grafts 69 Recombinant Human 69 Statistically Significant 69 Vaccine Adjuvant 69 Preclinical Models 69 Therapy Reduces 69 Contrast Agent 69 Improve Survival 69 Hematopoietic 69 Antiangiogenic 69 Inflammatory Markers 69 Therapeutic Vaccine 69 Pooled Analysis 69 Therapeutic Potential 69 Oral Spray 69 Lupus Drug 69 First Patient Enrolled 69 Peripheral Arterial 69 Relapsing Multiple Sclerosis 69 Knee Osteoarthritis 69 Newly Diagnosed Multiple Myeloma 69 HDAC Inhibitor 69 Lymph Node 69 Fluticasone 69 Bone Metastases 69 Chronic Lymphocytic Leukemia 69 Sustained Release 69 R lenalidomide 69 Decitabine 69 Malignant Melanoma 69 Gastrointestinal Stromal Tumors 69 ACE Inhibitors 69 Well Tolerated 69 Tezampanel 69 Safinamide 69 Oral Formulation 69 Therapeutic Antibody 69 Shows Statistically Significant 69 Renal Function 69 IN PATIENTS WITH 69 Embolic 69 Adjunctive Therapy 69 Unfractionated Heparin 68 Teva Provides Update 68 Efficacious 68 Investigational Agent 68 IND Filing 68 Mycophenolate Mofetil 68 Hepatic Encephalopathy 68 Tumor Growth 68 Adult Stem Cell Therapy 68 Advanced Colorectal Cancer 68 Left Ventricular 68 Radiofrequency Ablation 68 Recurrent Breast Cancer 68 Treatment Regimen 68 Subgroup Analysis 68 Paraplatin ® 68 Radiation Induced 68 Long Term Efficacy 68 Initiates Phase II 68 Diabetic Macular Edema 68 Immune Mediated 68 Novel Compound 68 Radioimmunotherapy 68 Idiopathic Pulmonary Fibrosis 68 Aflibercept 68 Antimicrobial Coating 68 Dupuytren Contracture 68 Heart Transplant Recipients 68 Antiviral Therapy 68 Sevelamer 68 Cardiotoxicity 68 Elagolix 68 Pediatric Patients 68 NAVISTAR R 68 Controlled Trial 68 Non Invasive Treatment 68 II Clinical Trial 68 Autoimmune Disease 68 Skeletal Muscle 68 Phase 2a Trial 68 Nilotinib 68 Immunomedics Announces 68 Diabetic Patients 68 Chronic Hepatitis B 68 Thromboembolic 68 Unresectable 68 Cutaneous T 68 Cytotoxic 68 Anti Tumor Activity 68 Advanced Pancreatic Cancer 68 Phase III Trial 68 Efficacy Trial 68 Diabetic Nephropathy 68 Keratitis 68 MEK Inhibitor 68 Septic Shock 68 Submits NDA 68 Patients Undergoing 68 Pivotal Study 68 Inflammatory Disease 68 Heart Failure Patients 68 Lung Cancer Survival 68 Placebo Controlled Trial 68 Fibrinogen 68 Less Invasive 68 Targeted Therapy 68 Treatment Resistant 68 Blood Pressure Drug 68 Initiates Clinical Trials 68 Localized Prostate Cancer 68 Breast Cancer Cells 68 Novel Antibiotic 68 Neuroendocrine Tumors 68 Cell Transplants 68 Venous Thromboembolism 68 Refractory Hodgkin Lymphoma 68 Chronic Heart Failure 68 Antitumor 68 metastatic malignant 68 Fracture Risk 68 Commercialize Novel 68 Confirmatory Phase 68 Smooth Muscle 68 Nanoemulsion 68 Systemic Delivery 68 Kinase Inhibitors 68 Trial Evaluating 68 Shows Efficacy 68 Mimetics 68 Kidney Function 68 Thrombus 68 Prostate Cancer Vaccine 68 Phase Ib Clinical Trial 68 acetonide FA 68 XOPENEX R 68 Vitro Activity 68 Anticoagulant 68 Nebulized 68 Nucleoside 68 ZEVALIN ® 68 Bacterial Vaginosis 68 Cancer Vaccines 68 RNAi Therapeutics 68 humanized monoclonal 68 FDA Clears 68 Advanced Prostate Cancer 68 Cilostazol 68 Chronic HCV 68 Myeloma Patients 68 Rotavirus Vaccine 68 Endometrial Cancer 68 Fludara ® 68 Enlarged Prostate 68 Anti Angiogenic 68 Bepreve TM 68 Motexafin Gadolinium 68 ISTODAX ® 68 Image Guided 68 Critical Limb Ischemia 68 Autologous Stem Cell Transplantation 68 Portal Hypertension 68 Myelodysplastic Syndrome MDS 67 Treatment Naïve 67 Preclinical Efficacy 67 Chemoradiation 67 Patients Treated 67 Successfully Treated 67 Chemokine Receptor 67 Neoadjuvant 67 Mucositis 67 Non Alcoholic Fatty 67 Significantly Improves 67 Diabetic Neuropathic Pain 67 Gene Linked 67 Relapsed Refractory 67 targeted radiotherapeutic 67 Fabry Disease 67 Lupus Nephritis 67 Develop Novel 67 Combination REOLYSIN R 67 Chronic Prostatitis 67 Taxane 67 Demonstrates Sustained 67 Generic Version 67 FOLOTYN ® 67 Ovarian Cancers 67 Inhaled Nitric Oxide 67 Epilepsy Drug 67 Announces FDA Clearance 67 Golimumab 67 Peginterferon 67 Asthma Treatment 67 diarrhea predominant irritable 67 Leukemias 67 Symptom Relief 67 Drug Resistant 67 Plus Ribavirin 67 Clinical Efficacy 67 Potent Anti 67 Wound Dressing 67 FDA Clearance 67 TO AVOID PREGNANCY WHILE 67 Psoriasis Drug 67 Gout Drug 67 Small Molecule 67 Asthma COPD 67 Chronic Bronchitis 67 Tumor Necrosis Factor 67 Novel Vaccine 67 Renin Inhibitor 67 Ecallantide 67 Inflammatory Pain 67 Blepharospasm 67 Vaginal Gel 67 Castration Resistant Prostate Cancer 67 Dendritic Cells 67 Myocardial Ischemia 67 Mg Usa 67 Radiofrequency Ablation RFA 67 Previously Untreated 67 Intravesical 67 Potent Inhibitor 67 Disease Modifying 67 Assay Kits 67 Breast Cancer Treatment 67 Methylnaltrexone 67 Lung Cancer Drug 67 Cancer Treatments 67 Appears Safe 67 CYT# potent vascular disrupting 67 Lung Tumors 67 Aztreonam Lysine 67 Vitrasert R 67 ST Elevation Myocardial 67 Pafuramidine 67 Glufosfamide 67 Adjunctive 67 Cardiomyocytes 67 Respiratory Distress 67 Cytotoxicity 67 Intracerebral Hemorrhage 67 Licenses Novel 67 Fatty Liver 67 Significantly Reduces 67 Chronic Renal Failure 67 Chemotherapeutic Agents 67 Circulating Tumor Cells 67 Phase III Clinical Trials 67 Synthetic Peptide 67 Investigational Drug 67 uricase 67 Thromboembolism 67 Study Demonstrates 67 Pivotal Trial 67 Inflammatory Arthritis 67 Bevacizumab 67 Intracranial Aneurysms 67 Cholesterol Lowering Drug 67 Parathyroid Hormone 67 Genes Predict 67 Fixed Dose 67 Angiotensin Converting Enzyme 67 Pivotal Phase III 67 Factor Receptor 67 Benign Prostatic Hyperplasia BPH 67 Pivotal Phase 67 Treated Patients 67 Lung Cancer Trial 67 Cardiovascular Disease Risk 67 Antibacterials 67 Photodynamic Therapy 67 Aneurysm Repair 67 Daptomycin 67 Restenosis 67 Epratuzumab 67 QUADRAMET R 67 Hepatitis C Virus 67 Tiotropium 67 Migraine Headaches 67 Ridaforolimus 67 Initiates Phase III 67 Ranolazine 67 Oral Cavity 67 Nicotine Vaccine 67 Uterine Cancer 67 Polymerase Inhibitor 67 Randomized Clinical Trials 67 Cypher Sirolimus 67 Cell Lymphoma 67 Double Blind Randomized 67 Aggressive Prostate Cancer 67 Presents Positive 67 Metabolic Disorder 67 Renal Artery 67 Relapsing Remitting Multiple Sclerosis 67 Aptamer 67 Antisense Drug 67 Urinary Tract Infections 67 Bladder Cancer 67 Valopicitabine 67 Reports Preclinical Data 67 Severe Asthma 67 COX Inhibiting Nitric Oxide 67 Potentially Fatal 67 Bronchodilator 66 Genetic Mutation 66 Intravitreal 66 Occlusive Disease 66 Stem Cell Treatment 66 Lubiprostone 66 Drug Combo 66 Maribavir 66 Therapeutic Competitors Companies 66 Placebo Controlled Study 66 Renal Impairment 66 platform HDL Mimetic 66 Liposomal 66 thalidomide Thalomid 66 Milestone Payments 66 See WARNINGS 66 Postmenopausal Osteoporosis 66 BARACLUDE R 66 Patent Covering 66 Protein Linked 66 Pelvic Organ Prolapse 66 Crit Rev 66 Non Invasive 66 Risk Stratification 66 Fluorouracil 66 Gene Mutation 66 GRAS Status 66 Moxifloxacin 66 Stent Coating 66 Topical Cream 66 Squamous 66 Peptic Ulcer 66 Study Showed 66 Interferon beta 66 Dose Escalation 66 Dry Powder Inhalers 66 Effectively Treats 66 Liver Cirrhosis 66 Bronchiectasis 66 Adenoviral 66 Microwave Ablation System 66 ORLive Presents 66 Estrogen Receptor 66 Preterm Delivery 66 Novel Therapeutic 66 targeted antifolate 66 Amphotericin B 66 Follicular Lymphoma 66 Naive Patients 66 Increased Mortality 66 Meta Analysis 66 Metastatic Cancer 66 Prognostic Significance 66 Anticancer Activity 66 oral prodrug 66 Completes Enrollment 66 Initiate Phase 66 Hospital Acquired Pneumonia 66 Anticancer Drug 66 Hematological Malignancies 66 ARIXTRA R 66 Fewer Side Effects 66 Novel Anti Inflammatory 66 FDA Accepts 66 Mitomycin C 66 Hepatitis C Genotype 66 Montelukast 66 Premature Infants 66 HCV Protease Inhibitor 66 Phase III Trials 66 Omacetaxine 66 Boosts Survival 66 Confirms Efficacy 66 Receives Approvable Letter 66 Dehydrogenase 66 Cardiovascular Events 66 C1 Inhibitor 66 Phase 1b Clinical Trial 66 Xyfid TM 66 Advanced Ovarian Cancer 66 Therapeutic Vaccines 66 Lymphocytic 66 Erythropoietic 66 Microplasmin 66 Telaprevir VX 66 Xenograft 66 Blood Clotting 66 Venous Thrombosis 66 Controlled Study 66 J Am Coll 66 Acute Lung 66 Tigecycline 66 Infected Patients 66 Drug Eluting 66 Stakeholder Opinions 66 OMNARIS HFA 66 Novel Therapies 66 Lung Cancer Patients 66 Disease IBD 66 Romidepsin 66 Genes Involved 66 Bloodstream Infections 66 Iron Deficiency 66 PKC# 66 Mylan Receives Approval 66 Prostate Cancer Treatment 66 Predict Risk 66 docetaxel Taxotere ® 66 Kepivance 66 Key Attributes 66 Nitazoxanide 66 HuMax 66 Premenopausal Women 66 Slow Progression 66 Posaconazole 66 Statin Drugs 66 Maven Semantic 66 Percutaneous Transluminal Coronary Angioplasty 66 endoluminal stent graft 66 Chronic Pelvic Pain 66 TNF Tumor Necrosis Factor 66 Fixed Dose Combination 66 vapreotide acetate 66 Myocardial Perfusion Imaging 66 Cell Transplant 66 Stress Urinary Incontinence 66 Conjugate 66 Subtypes 66 Pivotal Clinical Trial 66 Experimental Vaccine 66 Angioedema 66 Dual Antiplatelet Therapy 66 Lowers Risk 66 Cold Sores 66 Physician Insights 66 Abciximab 66 Arthritis Drug 66 Eluting Stent 66 Personalized Immunotherapy 66 von Willebrand Factor 66 Skin Structure Infections 66 Breast Cancer Metastasis 66 Alexion Soliris 66 PROSTASCINT R 66 Clinical Trial Evaluating 66 Corneal Transplant 66 Randomized Study 66 Prospective Multicenter 66 Announces Poster Presentations 66 SUPPRELIN R LA 66 Osteoporosis Drugs 66 brand ciclesonide HFA 66 Mucosal 66 Genes Associated 66 Friedreich Ataxia FRDA 66 Capecitabine 66 hypervascular tumors 66 ALN HPN 66 Randomized Controlled Trials 66 Receives CE Marking 66 complement inhibitor eculizumab 66 Psoriasis Patients 66 Mitoxantrone 66 Platinol ® 66 Malignant Glioma 66 Hypertensive Patients 66 Antithrombin 66 Skin Resurfacing 66 Antigen Specific 66 Plaque Psoriasis 66 Osteoporosis Drug 66 Insulin Delivery 66 Significantly Improved 66 Kuvan R 66 Tyrosine Kinase Inhibitors 66 Hepatitis C Treatment 66 Cyclooxygenase 2 66 pan HDAC inhibitor 66 Liver Metastases 66 Receives Milestone Payment 66 Innate Immune 66 GW# [003] 66 Prostate Cancer Patients 66 Denufosol 66 Renal Anemia 66 Conjugated 66 Azacitidine 66 Resistant Hypertension 66 Catheter Ablation 66 Novel Approaches 66 Bacteremia 66 Effective Treatments 66 Surgical Procedures 66 Ultrasensitive 66 Demonstrates Statistically Significant 66 Neulasta ® 66 dual endothelin receptor antagonist 66 HepaLife TM 66 Periodontal Disease 66 Versus Placebo 66 Intravenous Formulation 66 Liver Failure 66 Signaling Pathway 66 Onychomycosis 66 Orthostatic Hypotension 66 Pegylated Liposomal Doxorubicin 66 Colorectal Cancer Patients 66 Inhalation Aerosol 66 PROCRIT R 66 Non Responders 65 Retinoic Acid 65 Protease Inhibitors 65 Showed Significant 65 Adipose Derived Stem Cells 65 Progressive Multifocal Leukoencephalopathy 65 ADP receptor antagonist 65 Anti Fungal 65 Receives SFDA Approval 65 Critically Ill Patients 65 THERAPEUTICS 65 Chronic Liver Disease 65 IV Busulfex 65 kidney urologic 65 TB Vaccine 65 Electrical Stimulation 65 Gastrointestinal Disorders 65 Atrial Flutter 65 Viral Infections 65 Oral Calcitonin 65 TRANSDUR ™ 65 Trastuzumab 65 Genital Herpes 65 Multiple Myeloma Patients 65 Antiplatelet Therapy 65 Ovarian Cancer Patients 65 Myoblast 65 Solid Tumor 65 Treatment Experienced 65 Pemphigus Vulgaris 65 topical non steroidal 65 R Saizen R 65 Romiplostim 65 Carotid Stenting 65 Cytarabine 65 Dose Ranging Study 65 Monotherapy 65 Palonosetron 65 invasive candidiasis 65 TLK# 65 Pegylated 65 Itraconazole 65 Seasonal Influenza Vaccine 65 Therapeutic Antibodies 65 Peginterferon Alfa 2a 65 Hepatitis C Infection 65 RECOTHROM R 65 Shown Effective 65 CT Angiography 65 Lung Injury 65 Inflammatory Diseases 65 familial amyloidotic polyneuropathy FAP 65 Ischemic Stroke 65 Glatiramer Acetate 65 methylnaltrexone bromide 65 Infarct 65 Breast Density 65 Platelet Inhibition 65 Sustained Efficacy 65 Enzyme Replacement Therapy 65 Valsartan 65 Chronic Myelogenous Leukemia 65 Uric Acid 65 cheilitis 65 Nerve Regeneration 65 Emollient Foam 65 Retinal Vein Occlusion 65 Treatment Naive Patients 65 Platelet Function 65 injectable bulking agent 65 Pemetrexed 65 AVONEX ® 65 Fidaxomicin 65 Total Knee Arthroplasty 65 Zorbtive TM 65 Emerging Therapies 65 Test Detects 65 Aerosolized 65 Bare Metal Stent 65 Valve Replacement 65 Initiates Dosing 65 Peripheral Blood 65 IMiDs ® compound 65 including thyroiditis RA 65 Quantitation 65 Botulinum Toxin 65 Anti Inflammatory 65 siRNA Delivery 65 Oracea ® 65 Interferon Alpha 65 Beta Blocker 65 Genotyping Test 65 Xerostomia 65 Pertuzumab 65 Parenteral Nutrition 65 Chemotherapy Regimen 65 Contrast Enhanced 65 Metabolic Endocrinology 65 INFeD ® 65 Bivalirudin 65 Atypical Antipsychotic 65 Eculizumab 65 leiomyomas 65 Metastatic Renal Cell Carcinoma 65 Factor VIIa 65 Medoxomil 65 Pharmacodynamics 65 Etanercept 65 severe oral mucositis 65 Surgical Sealant 65 Refractory Angina 65 Reduces Pain 65 Inhaled Insulin 65 proprietary polysaccharide 65 Randomized Phase 65 Treat Anemia 65 orally administered inhibitor 65 Antiviral Activity 65 Long Term Survival 65 Allergic Asthma 65 Reduces Mortality 65 essential thrombocythemia ET 65 lucinactant 65 histone deacetylase HDAC inhibitor 65 Genetic Marker 65 Migraine Pain 65 Vidaza azacitidine 65 Interferon beta 1a 65 Colorectal Adenomas 65 Fibromyalgia Pain 65 Stomach Cancer 65 Protein Expression 65 Sapacitabine 65 Pneumococcal Vaccine 65 Modulates 65 Viral Load 65 Oral Presentations 65 Urinary Incontinence 65 BUPHENYL R 65 Breast Cancer Assay 65 Antibiotic Resistant 65 Autoimmune Disorders 65 Clostridium difficile Infection 65 Cardiometabolic 65 Artery Disease 65 Glucocorticoid 65 MetroGel 65 Blood Cancers 65 Sinus Infections 65 Cellular Immunotherapy 65 Muscle Wasting 65 Generic Versions 65 Orally administered 65 Tesetaxel 65 Gene Variant 65 candidates Azedra 65 PHASE III 65 Cancer Recurrence 65 Anti Inflammatory Drugs 65 Caphosol 65 Mg Uk 65 ST Segment Elevation 65 Patient Outcomes 65 Embolic Protection Device 65 candidates Azedra TM 65 HCV Genotype 65 Focused Ultrasound 65 Liprotamase 65 Squamous Cell Carcinoma 65 Onyx Pharmaceuticals Announces 65 Cocaine Addiction 65 #mg Tablets [002] 65 Microspheres 65 Chemotherapy induced 65 VIVITROL ® 65 Antifungals 65 Tacrolimus 65 Cervical Dystonia 65 mertansine 65 Hepatitis B Virus 65 Receptor Antagonist 65 Pegylated Interferon 65 Pazopanib 65 anti infective treatments 65 Virologic 65 Seasonal Allergic Rhinitis 65 Deep Venous Thrombosis 65 treat chronic sinusitis 65 Bucindolol Based 65 Chronic Myeloid Leukemia 65 Levels Linked 65 5 Fluorouracil 65 Cell Adhesion 65 BiTE Antibody 65 Warfarin Coumadin 65 Biomarker Study 65 pan histone deacetylase 65 Ketorolac 65 Vascular Targeting Agents 65 Growth Hormone Deficiency 65 Enoxaparin 65 Melphalan 65 Suicidality 65 abacavir sulfate lamivudine 65 DNA Methylation 65 Fluconazole 65 Squalamine 65 Androgen Deprivation Therapy 65 Data Suggest 65 Rilonacept 65 Initiate Phase II 65 Receives Positive Opinion 65 SPRYCEL ® 65 Pharmacokinetics PK 65 Efficacy Results 65 Carotid 65 Signaling Pathways 65 Contrast Induced Nephropathy 65 metastatic neuroendocrine tumors 65 Treatment Shows Promise 65 Hernia Repair 65 histone deacetylase inhibitor 65 Acute Renal Failure 65 Genetic Markers 65 HuMax EGFr 65 Diastolic Heart Failure 65 Organ Rejection 65 BCG refractory carcinoma 65 Critical Limb Ischemia CLI 65 Calcitonin 65 Bosutinib 65 Atypical Hemolytic Uremic Syndrome 65 Cinacalcet 65 HCl Tablets 65 Protein Synthesis 65 Alvine Pharmaceuticals 65 Presents Preclinical 65 KL4 Surfactant 65 Hepatotoxicity 65 Kidney Transplant Recipients 65 Improve Outcomes 65 Reduces Risk 65 Irinotecan 65 Palifosfamide 65 Hypertriglyceridemia 65 Injury ALI 65 Intrathecal 65 Statin Therapy 65 Esophagitis 65 Neovascularization 65 Hepatocellular 65 Lymphoma Patients 65 Tumor Suppressor 65 Occlusion 65 liposomal formulation 65 Fulvestrant 65 Postherpetic Neuralgia 65 Wound Closure 65 transthyretin TTR mediated amyloidosis 65 Guidelines Issued 65 Attenuates 65 Obese Patients 65 Rheumatoid 65 investigational oral inhibitor 65 Vertebral Fractures 65 Anticancer Drugs 65 Chemotherapeutic 65 Receptor Agonist 65 Degarelix 65 invasive aspergillosis 65 Genetic Variant 65 Camptosar ® 65 Severe Acne 65 Endothelial 65 Antibody Drug Conjugate 65 Maleate 65 MR Angiography 65 Diffuse Large B 64 Surgical Treatment 64 Pegloticase 64 Angiogenic 64 Community Acquired Pneumonia 64 Demonstrated Significant 64 Primary Hypercholesterolemia 64 Acute Coronary Syndromes 64 SinoFresh TM 64 Adenoma 64 Lenalidomide 64 NASH Huntington